DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models

BACKGROUND: Systemic sclerosis is a multisystem inflammatory and vascular lesion leading to extensive tissue fibrosis. A reversible S-adenosyl-l-homocysteine hydrolase (SAHH) inhibitor, DZ2002, modulates the pathologic processes of various inflammatory diseases and autoimmune diseases. This study is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zongwang, Wu, Yanwei, Wu, Bing, Qi, Qing, Li, Heng, Lu, Huimin, Fan, Chen, Feng, Chunlan, Zuo, Jianping, Niu, Lili, Tang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916442/
https://www.ncbi.nlm.nih.gov/pubmed/31842999
http://dx.doi.org/10.1186/s13075-019-2074-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916442/
https://www.ncbi.nlm.nih.gov/pubmed/31842999
http://dx.doi.org/10.1186/s13075-019-2074-9

Ejemplares similares